AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.06 Decreased By ▼ -0.47 (-0.36%)
BOP 6.75 Increased By ▲ 0.07 (1.05%)
CNERGY 4.49 Decreased By ▼ -0.14 (-3.02%)
DCL 8.55 Decreased By ▼ -0.39 (-4.36%)
DFML 40.82 Decreased By ▼ -0.87 (-2.09%)
DGKC 80.96 Decreased By ▼ -2.81 (-3.35%)
FCCL 32.77 No Change ▼ 0.00 (0%)
FFBL 74.43 Decreased By ▼ -1.04 (-1.38%)
FFL 11.74 Increased By ▲ 0.27 (2.35%)
HUBC 109.58 Decreased By ▼ -0.97 (-0.88%)
HUMNL 13.75 Decreased By ▼ -0.81 (-5.56%)
KEL 5.31 Decreased By ▼ -0.08 (-1.48%)
KOSM 7.72 Decreased By ▼ -0.68 (-8.1%)
MLCF 38.60 Decreased By ▼ -1.19 (-2.99%)
NBP 63.51 Increased By ▲ 3.22 (5.34%)
OGDC 194.69 Decreased By ▼ -4.97 (-2.49%)
PAEL 25.71 Decreased By ▼ -0.94 (-3.53%)
PIBTL 7.39 Decreased By ▼ -0.27 (-3.52%)
PPL 155.45 Decreased By ▼ -2.47 (-1.56%)
PRL 25.79 Decreased By ▼ -0.94 (-3.52%)
PTC 17.50 Decreased By ▼ -0.96 (-5.2%)
SEARL 78.65 Decreased By ▼ -3.79 (-4.6%)
TELE 7.86 Decreased By ▼ -0.45 (-5.42%)
TOMCL 33.73 Decreased By ▼ -0.78 (-2.26%)
TPLP 8.40 Decreased By ▼ -0.66 (-7.28%)
TREET 16.27 Decreased By ▼ -1.20 (-6.87%)
TRG 58.22 Decreased By ▼ -3.10 (-5.06%)
UNITY 27.49 Increased By ▲ 0.06 (0.22%)
WTL 1.39 Increased By ▲ 0.01 (0.72%)
BR100 10,445 Increased By 38.5 (0.37%)
BR30 31,189 Decreased By -523.9 (-1.65%)
KSE100 97,798 Increased By 469.8 (0.48%)
KSE30 30,481 Increased By 288.3 (0.95%)

Denmark said on Thursday it would create an international research centre focused on the fight against resistance to antibiotics, a scourge affecting almost half a million people worldwide. Danish Health Minister Ellen Trane Norby signed a memorandum of understanding in Seattle, in the United States, with the international network of research centres CGIAR, to establish the centre, her office told AFP.
Denmark aims to lead "future global work on finding new solutions for the serious challenges with antimicrobial resistance we are facing today," Norby said in a statement. The International Centre for Interdisciplinary Solutions on AMR (Antimicrobial Resistance), financed by Denmark and private investors, will open in 2019 and is expected to employ up to 500 people.
In 2016, 490,000 people developed a resistance to antibiotics, according to figures from the World Health Organisation. The growing problem causes 33,000 deaths in Europe each year, a recent study by the Stockholm-based European Centre for Disease Prevention and Control (ECDC) said. "The burden of these infections is comparable to that of influenza, tuberculosis and HIV/AIDS combined," the ECDC said. Discovered in the 1920s, antibiotics have saved tens of millions of lives by defeating bacterial diseases such as pneumonia, tuberculosis and meningitis. But over the decades, bacteria have learned to fight back, building resistance to the same drugs that once reliably vanquished them.
The WHO has repeatedly warned the world is running out of effective antibiotics, and last year urged governments and big pharma companies to create a new generation of drugs to fight ultra-resistant supergerms. Bacteria can become resistant when patients use antibiotics they do not need, or do not finish a course of treatment, giving the half-defeated bug a chance to recover and build immunity.

Copyright Agence France-Presse, 2018

Comments

Comments are closed.